SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion.
Saved in:
| Title: | SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion. |
|---|---|
| Authors: | Ferreira IATM; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Cambridge,United Kingdom.; Department of Medicine, University of Cambridge, Cambridge,United Kingdom., Kemp SA; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Cambridge,United Kingdom.; Department of Medicine, University of Cambridge, Cambridge,United Kingdom., Datir R; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Cambridge,United Kingdom.; Department of Medicine, University of Cambridge, Cambridge,United Kingdom., Saito A; Department of Veterinary Medicine, Faculty of Agriculture, University of Miyazaki, Miyazaki,Japan., Meng B; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Cambridge,United Kingdom.; Department of Medicine, University of Cambridge, Cambridge,United Kingdom., Rakshit P; National Centre for Disease Control, Delhi,India., Takaori-Kondo A; Department of Hematology and Oncology, Kyoto University, Kyoto,Japan., Kosugi Y; Division of Systems Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan., Uriu K; Division of Systems Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan., Kimura I; Division of Systems Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan., Shirakawa K; Department of Hematology and Oncology, Kyoto University, Kyoto,Japan., Abdullahi A; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Cambridge,United Kingdom.; Department of Medicine, University of Cambridge, Cambridge,United Kingdom., Agarwal A; CSIR Institute of Genomics and Integrative Biology, Delhi,India., Ozono S; Department of Pathology, National Institute of Infectious Diseases, Tokyo,Japan., Tokunaga K; Department of Pathology, National Institute of Infectious Diseases, Tokyo,Japan., Sato K; Division of Systems Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.; CREST , Japan Science and Technology Agency, Saitama,Japan., Gupta RK; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Cambridge,United Kingdom.; Department of Medicine, University of Cambridge, Cambridge,United Kingdom.; Africa Health Research Institute, Durban,South Africa. |
| Corporate Authors: | CITIID-NIHR BioResource COVID-19 Collaboration, Indian SARS-CoV-2 Genomics Consortium, Genotype to Phenotype Japan (G2P-Japan) Consortium |
| Source: | The Journal of infectious diseases [J Infect Dis] 2021 Sep 17; Vol. 224 (6), pp. 989-994. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34260717 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ferreira+IATM%22">Ferreira IATM</searchLink>; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Cambridge,United Kingdom.; Department of Medicine, University of Cambridge, Cambridge,United Kingdom.<br /><searchLink fieldCode="AU" term="%22Kemp+SA%22">Kemp SA</searchLink>; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Cambridge,United Kingdom.; Department of Medicine, University of Cambridge, Cambridge,United Kingdom.<br /><searchLink fieldCode="AU" term="%22Datir+R%22">Datir R</searchLink>; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Cambridge,United Kingdom.; Department of Medicine, University of Cambridge, Cambridge,United Kingdom.<br /><searchLink fieldCode="AU" term="%22Saito+A%22">Saito A</searchLink>; Department of Veterinary Medicine, Faculty of Agriculture, University of Miyazaki, Miyazaki,Japan.<br /><searchLink fieldCode="AU" term="%22Meng+B%22">Meng B</searchLink>; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Cambridge,United Kingdom.; Department of Medicine, University of Cambridge, Cambridge,United Kingdom.<br /><searchLink fieldCode="AU" term="%22Rakshit+P%22">Rakshit P</searchLink>; National Centre for Disease Control, Delhi,India.<br /><searchLink fieldCode="AU" term="%22Takaori-Kondo+A%22">Takaori-Kondo A</searchLink>; Department of Hematology and Oncology, Kyoto University, Kyoto,Japan.<br /><searchLink fieldCode="AU" term="%22Kosugi+Y%22">Kosugi Y</searchLink>; Division of Systems Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Uriu+K%22">Uriu K</searchLink>; Division of Systems Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Kimura+I%22">Kimura I</searchLink>; Division of Systems Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Shirakawa+K%22">Shirakawa K</searchLink>; Department of Hematology and Oncology, Kyoto University, Kyoto,Japan.<br /><searchLink fieldCode="AU" term="%22Abdullahi+A%22">Abdullahi A</searchLink>; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Cambridge,United Kingdom.; Department of Medicine, University of Cambridge, Cambridge,United Kingdom.<br /><searchLink fieldCode="AU" term="%22Agarwal+A%22">Agarwal A</searchLink>; CSIR Institute of Genomics and Integrative Biology, Delhi,India.<br /><searchLink fieldCode="AU" term="%22Ozono+S%22">Ozono S</searchLink>; Department of Pathology, National Institute of Infectious Diseases, Tokyo,Japan.<br /><searchLink fieldCode="AU" term="%22Tokunaga+K%22">Tokunaga K</searchLink>; Department of Pathology, National Institute of Infectious Diseases, Tokyo,Japan.<br /><searchLink fieldCode="AU" term="%22Sato+K%22">Sato K</searchLink>; Division of Systems Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.; CREST , Japan Science and Technology Agency, Saitama,Japan.<br /><searchLink fieldCode="AU" term="%22Gupta+RK%22">Gupta RK</searchLink>; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Cambridge,United Kingdom.; Department of Medicine, University of Cambridge, Cambridge,United Kingdom.; Africa Health Research Institute, Durban,South Africa. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22CITIID-NIHR+BioResource+COVID-19+Collaboration%2C+Indian+SARS-CoV-2+Genomics+Consortium%22">CITIID-NIHR BioResource COVID-19 Collaboration, Indian SARS-CoV-2 Genomics Consortium</searchLink><br /><searchLink fieldCode="CA" term="%22Genotype+to+Phenotype+Japan+%28G2P-Japan%29+Consortium%22">Genotype to Phenotype Japan (G2P-Japan) Consortium</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220413675%22">The Journal of infectious diseases</searchLink> [J Infect Dis] 2021 Sep 17; Vol. 224 (6), pp. 989-994. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0413675 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6613 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200221899%22">00221899 </searchLink><i>NLM ISO Abbreviation: </i>J Infect Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34260717 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/infdis/jiab368 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 989 Titles: – TitleFull: SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ferreira IATM – PersonEntity: Name: NameFull: Kemp SA – PersonEntity: Name: NameFull: Datir R – PersonEntity: Name: NameFull: Saito A – PersonEntity: Name: NameFull: Meng B – PersonEntity: Name: NameFull: Rakshit P – PersonEntity: Name: NameFull: Takaori-Kondo A – PersonEntity: Name: NameFull: Kosugi Y – PersonEntity: Name: NameFull: Uriu K – PersonEntity: Name: NameFull: Kimura I – PersonEntity: Name: NameFull: Shirakawa K – PersonEntity: Name: NameFull: Abdullahi A – PersonEntity: Name: NameFull: Agarwal A – PersonEntity: Name: NameFull: Ozono S – PersonEntity: Name: NameFull: Tokunaga K – PersonEntity: Name: NameFull: Sato K – PersonEntity: Name: NameFull: Gupta RK IsPartOfRelationships: – BibEntity: Dates: – D: 17 M: 09 Text: 2021 Sep 17 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1537-6613 Numbering: – Type: volume Value: 224 – Type: issue Value: 6 Titles: – TitleFull: The Journal of infectious diseases Type: main |
| ResultId | 1 |